Serbest nakit akışı · 2025 mali yılı
| 1 | Johnson & JohnsonJNJ | $19,7B |
|---|---|---|
| 2 | AbbVieABBV | $17,8B |
| 3 | UnitedHealth GroupUNH | $16,1B |
| 4 | Bristol Myers SquibbBMY | $12,8B |
| 5 | MerckMRK | $12,4B |
| 6 | AstraZenecaAZN | $11,8B |
| 7 | Gilead SciencesGILD | $9,5B |
| 8 | PfizerPFE | $9,1B |
| 9 | Novo Nordisk A SNVO | $8,9B |
| 10 | Cigna GroupCI | $8,6B |